Improvements throughout the Three Waves of COVID-19 Pandemic: Results from 4 Million Inhabitants of North-West Italy.
SARS-CoV-2
comorbidity
epidemiology
intensive care units
mortality
patients
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
25 Jul 2022
25 Jul 2022
Historique:
received:
21
06
2022
revised:
13
07
2022
accepted:
19
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
At the very beginning of the European spread of SARS-CoV-2, Piedmont was one of the most affected regions in Italy, with a strong impact on healthcare organizations. In this study, we evaluated the characteristics and outcomes of the COVID-19 patients in an entire region during the first three pandemic waves, identifying similarities and differences in the SARS-CoV-2 epidemic's timeline. We collected the health-administrative data of all the Piedmont COVID-19 patients infected during the first three pandemic waves (1 March 2020-15 April 2020; 15 October 2020-15 December 2020; 1 March 2021-15 April 2021, respectively). We compared differences among the waves in subjects positive for SARS-CoV-2 and in patients admitted to ICU. Overall, 18.621 subjects tested positive during the first wave (405 patients/day), 144.350 (2366.4 patients/day) in the second, and 81.823 (1778.8 patients/day) in the third. In the second and third waves, we observed a reduction in median age, comorbidity burden, mortality in outpatients, inpatients, and patients admitted to ICU, in intubation, invasive ventilation and tracheostomy, and a parallel increase in the use of CPAP. Our study confirmed a trend towards younger and healthier patients over time but also showed an independent effect of the period on mortality and ICU admission. The appearance of new viral variants, the starting of vaccination, and organizational improvements in tracking, outpatients and inpatients management could have influenced these trends.
Identifiants
pubmed: 35893395
pii: jcm11154304
doi: 10.3390/jcm11154304
pmc: PMC9332615
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Environ Res. 2021 Jun;197:111097
pubmed: 33811866
J Clin Med. 2020 May 21;9(5):
pubmed: 32455807
JCO Oncol Pract. 2021 Dec;17(12):e1887-e1894
pubmed: 34228511
J Infect. 2021 Apr;82(4):84-123
pubmed: 33152376
Acta Biomed. 2021 May 12;92(2):e2021171
pubmed: 33988144
Int J Environ Res Public Health. 2020 Nov 24;17(23):
pubmed: 33255181
Biosci Trends. 2021 Mar 15;15(1):1-8
pubmed: 33518668
J Infect. 2021 Jul;83(1):e16
pubmed: 33992688
Lancet. 2021 Apr 3;397(10281):1265-1275
pubmed: 33773118
Int J Infect Dis. 2021 Jun;107:300-310
pubmed: 33444752
Int J Epidemiol. 2020 Oct 1;49(5):1468-1481
pubmed: 32887982
Eur Respir J. 2021 Apr 15;57(4):
pubmed: 33692120
Acute Med. 2021;20(2):92-100
pubmed: 34190735
J Infect. 2021 Jul;83(1):e32-e33
pubmed: 33932448
Public Health. 2021 Apr;193:41-42
pubmed: 33725494
Int J Epidemiol. 2021 Jan 23;49(6):1909-1917
pubmed: 33053172
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Dtsch Arztebl Int. 2021 May 7;118(18):326-327
pubmed: 34140083
PLoS One. 2021 Apr 26;16(4):e0250730
pubmed: 33901228
PLoS One. 2021 Mar 31;16(3):e0248029
pubmed: 33788866
Crit Care. 2021 Jan 4;25(1):3
pubmed: 33397421
Innovation (Camb). 2020 Aug 28;1(2):100022
pubmed: 33521759
J Orthop. 2021 Mar-Apr;24:A1-A3
pubmed: 33519131
Lancet Reg Health Am. 2021 Nov;3:100041
pubmed: 34423331
Engineering (Beijing). 2021 Sep 14;:
pubmed: 34540319
Infect Dis (Lond). 2021 May;53(5):370-375
pubmed: 33560897
Infect Dis Now. 2022 Feb;52(1):35-39
pubmed: 34634485
J Public Health Res. 2021 Oct 06;11(1):
pubmed: 34615342